{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"Grade 1/2 anemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 sinus bradycardia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 sinus tachycardia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 eye pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 watering eyes"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"Grade 1/2 nausea"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"title":"Grade 1/2 oral dysesthesia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 chills"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Grade 1/2 fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 fever"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 infusion related reaction"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}],"title":"Grade 1/2 injection site reaction"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 localized edema"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 vibration sensation"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}],"title":"Grade 1/2 allergic reaction"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 papulopustular rash"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 bruising"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 hemoglobin increased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"title":"Grade 1/2 lymphocyte count decreased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 3 lymphocyte count decreased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}],"title":"Grade 1/2 lymphocyte count increased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}],"title":"Grade 1/2 platelet count decreased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 weight loss"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 white blood cell decreased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 A1c increased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 hyperglycemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 hyperkalemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}],"title":"Grade 1/2 hypocalcemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 hypomagnesemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 arthralgia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 bone pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 foot pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 numbness in arms"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 pain in extremity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 dysesthesia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 dizziness"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 dysgeusia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Grade 1/2 headache"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Grade 1/2 paresthesia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Grade 1/2 dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}],"title":"Grade 1/2 hypertension"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"title":"Grade 3 hypertension"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 1/2 hypotension"}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"-Adverse events will be graded according to the NCI CTCAE version 4.03","groups":[{"description":"-Donors will receive subcutaneous (SC) BL-8040 in the morning (Day 1) followed by leukapheresis approximately 180 minutes (up to 270 minutes) after the injection per institutional protocol. If the donor does not reach the collection goal for mobilization (≥ 5.0 x 10\\^6 CD34+ cells/kg), a second leukapheresis will be performed on Day 2 (24 hours ± 2 hours from the BL-8040 injection) in an effort to reach a total of ≥ 5 x 10\\^6 CD34+ cells/kg and at least ≥ 2 x 10\\^6 CD34+ cells/kg from the combined collections.","id":"OG000","title":"Arm 1: Donors"},{"description":"-All or part of the leukapheresis product will be infused into the recipient per institutional guidelines. The day of the infusion will be considered Day 0; if the infusion occurs over multiple days, the final day of infusion will be considered Day 0","id":"OG001","title":"Arm 2: Recipients"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"This outcome measure is for Donor Arm only.","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Safety and Tolerability of BL-8040 in Healthy Donors as Measured by Number and Grade of Adverse Events (Arm 1 Donors Only)","type":"SECONDARY","unitOfMeasure":"Participants"}